ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 2888

$1.02M Total Retail Price of All Prescriptions

Rank: 209 out of 2888

917 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 917 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 19,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 2,069 1,798 1 2
LISINOPRIL 1,760 1,590 2 3
METFORMIN HCL 1,132 909 3 8
AMLODIPINE BESYLATE 953 848 4 5
LEVOTHYROXINE SODIUM 673 610 5 1
HYDROCODONE-ACETAMINOPHEN 647 401 S3 6 4
GLIPIZIDE 593 482 7 50
ENALAPRIL MALEATE 557 442 8 49
CARVEDILOL 519 451 9 21
OMEPRAZOLE 503 429 10 7
METOPROLOL TARTRATE 474 437 11 10
HYDROCHLOROTHIAZIDE 461 412 12 15
GABAPENTIN 414 342 13 13
LOVASTATIN 394 337 14 41
JANUVIA 392 306 15 48
ATORVASTATIN CALCIUM 364 291 16 9
TRAMADOL HCL 338 294 17 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 311 281 18 28
METOPROLOL SUCCINATE 275 218 19 11
NEXIUM 263 145 20 19
HYDRALAZINE HCL 248 238 21 59
FUROSEMIDE 242 199 22 6
DOXAZOSIN MESYLATE 239 220 23 94
ATENOLOL 206 197 24 25
LOSARTAN POTASSIUM 196 168 25 18
RANITIDINE HCL 180 142 26 56
METFORMIN HCL ER 176 152 27 53
PRAVASTATIN SODIUM 172 135 28 12
CLOPIDOGREL 171 145 29 30
CITALOPRAM HBR 165 145 30 24
ISOSORBIDE MONONITRATE ER 159 147 31 51
BENAZEPRIL HCL 158 149 32 77
LANTUS 155 143 33 45
DIOVAN HCT 151 141 34 61
INSULIN SYRINGE 134 109 35 86
TAMSULOSIN HCL 133 120 36 29
AMLODIPINE BESYLATE-BENAZEPRIL 131 107 37 67
GLYBURIDE 124 108 R 38 58
DIOVAN 122 117 39 35
FELODIPINE ER 121 121 40 175
ALENDRONATE SODIUM 120 120 41 23
TERAZOSIN HCL 113 105 42 152
PLAVIX 111 95 43 40
BENICAR 108 96 44 138
LOSARTAN-HYDROCHLOROTHIAZIDE 107 95 45 46
VESICARE 105 104 46 154
BENICAR HCT 103 103 47 181
DILTIAZEM ER 103 91 47 182
TRICOR 102 65 49 91
GLYBURIDE-METFORMIN HCL 102 84 R 49 64
POTASSIUM CHLORIDE 101 87 51 14
CLONIDINE HCL 98 95 52 39
BYSTOLIC 97 87 53 99
NOVOLIN 70-30 97 77 53 144
WARFARIN SODIUM 94 79 55 22
NAMENDA 92 92 56 34
VYTORIN 90 77 57 155
DILTIAZEM 24HR CD 89 89 58 146
CYCLOBENZAPRINE HCL 89 76 R 58 68
SPIRIVA 84 64 60 79
LACTULOSE 84 57 60 111
TRAZODONE HCL 81 59 62 43
LIPITOR 80 61 63 78
PEN NEEDLE 79 47 64 110
VERAPAMIL ER 79 67 64 104
ESCITALOPRAM OXALATE 78 71 66 62
DONEPEZIL HCL 77 77 67 26
SERTRALINE HCL 76 52 68 27
SURE COMFORT 71 57 69 276
OXYBUTYNIN CHLORIDE ER 71 45 69 132
GEMFIBROZIL 69 64 71 98
LANTUS SOLOSTAR 67 49 72 92
BENAZEPRIL-HYDROCHLOROTHIAZIDE 65 61 73 254
GLIPIZIDE-METFORMIN 63 50 74 293
PAROXETINE HCL 63 54 74 84
CIPROFLOXACIN HCL 62 56 76 47
JANUMET 60 54 77 131
DIGOXIN 59 57 78 55
ADVAIR DISKUS 58 35 79 60
LYRICA 57 13 80 69
FLUOXETINE HCL 57 36 80 83
PREDNISONE 56 35 82 42
FLUTICASONE PROPIONATE 56 41 82 32
CYMBALTA 53 36 84 44
ROPINIROLE HCL 53 49 84 115
AMITRIPTYLINE HCL 52 15 R 86 74
GLIPIZIDE ER 52 46 86 107
CLONIDINE 51 47 88 247
PROAIR HFA 50 26 89 71
SPIRONOLACTONE 50 50 89 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.